HAMBURG, Germany ― Once-weekly tirzepatide (Mounjaro, Lilly) added to insulin glargine resulted in greater reductions in A1c along with more weight loss and less hypoglycemia compared with prandial ...
Rate of combined clinically significant or severe hypoglycemia significantly lower with efsitora versus glargine. (HealthDay News) — Once-weekly insulin efsitora alpha (efsitora) is noninferior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results